VEGF: an update on biological and therapeutic aspects
Top Cited Papers
- 27 November 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 11 (6) , 617-624
- https://doi.org/10.1016/s0958-1669(00)00153-1
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Inducible Gene Targeting in MiceScience, 1995
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndromeThe Lancet, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986